2022-12-31-accounts

			Page
Report of the Trustees		I	to	4
Independent Examiner's	Report
Statement of Financial	Activities
Balance Sheet		7	to	8
Notes to the Financial Statements		9	to	l5
Detailed Statement ofFinancial Activities			16

Registered office
Executive Business Support
Davidson Road
Lichfield
Staffordshire
WSI49DZ
Trustees
Professor M Heneghan Consultant Hepatologist	(resigned	24.9.22)
Professor B R Davidson Hepatobiliary and Transplant Consultant
DrJW Ferguson Consultant Hepatologist (resigned 24.9.22)
Dr TJ Kendall Senior Clinical Fellow In Pathology
Dr I A C Rowe University Clinical Academic Fellow
Dr S M Rushbrook Consultant Gastroentrologist	(resigned	24.9.22)
Dr V Snowdon Consultant Hepatologist
Ms M BClayton Lecturer In Liver Care
Dr M A Aldersley Consultant Hepatologist (resigned l.2.23)
Dr KJ Simpson Consultant Physician and Senior	Lecturer
Dr V R Aluvihare Transplant Hepatologist (resigned 24.9.22)
Professor F Oakley Professor of Fibrosis Biology	(resigned	24.9.22)
Professor M E Cramp Consultant Hepatologist (appointed		23.9.22)
Dr A M Elsharkawy Consultant Hepatologist (appointed 23.9,22)
Dr RJones Consultant Hepatologist
Dr K Drysale Hepatolgy Registrar Clinical Research (resigned			3I.I.23)
Professor R Mookerjee Professor ofTranslational	Hepatology		(appointed		23.9.22)
Dr M Allison Consultant Hepatologist (appointed	23.9.22)
Dr S Chokshi Acting Director &Chief Scientific	Offic (appointed			23.9.22)

							2022	2021
					Unrestricted	Restricted	Total	Total
					funds	funds	funds	funds
			Notes
INCOME AND ENDOWMENTS			FROM
Membership subscriptions					99,160		99,160	94,339
Conference fees &sponsorship		income			297,904		297,904	128,371
Interest receivable					828		828	748
Total					397,892		397,892	223,458
EXPENDITURE ON
Conference costs
Direct conference costs					206,048		206,048	43,461
Other associated conference	costs				197,398		197,398	117,442
					403,446		403,446	160,903
Other					13,476		13,476
Total					416,922		416,922	160,903
NET INCOME/(EXPENDITURE)					(19,030)		(19,030)	62,555
RECONCILIATION OF	FUNDS
Total funds brought forward					144,031	22,377	166,408	103,853
TOTAL FUNDS CARRIED		FORWARD			125,001	22,377	147,378	166,408
CONTINUING OPERATIONS
All income and expenditure	has	arisen	from continuing	activities.

					Balance Sheet	Balance Sheet
					31 DECEMBER 2022
								2022	2021
						Unrestricted	Restricted	Total	Total
						funds	funds	funds	funds
					Notes			f
FIXEDASSETS
Investments					12
CURRENT ASSETS
Debtors: amounts		falling due within one year			13	17,893		17,893	14,464
Cash ar. bank						184,360	22,377	206,737	211,358
						202,253	22,377	224,630	225,822
CREDITORS
Amounts falling	due		within	one year	14	(45,129)		(45,129)	(28,029)
NET CURRENT		ASSETS				157,124	22,377	179,501	197,793
TOTAL ASSETS			LESS	CURRENT
LIABILITIES						157,125	22,377	179,502	197,794
CREDITORS
Amounts falling	due		after more than one year		15	(32,124)		(32,124)	(31,386)
NET ASSETS						125,001	22,377	147,378	166,408
FUNDS					16
Unrestricted funds:
General fund								125,001	144,031
Restricted funds:
BASL nurses	fund							6,627	6,627
CCA UK Neil Blenkinsop				donation for research				15,750	15,750
only
								22,377	22,377
TOTAL FUNDS								147,378	166,408

			2022	202I
			E
	Interest receivable		828	748
6.	DIRECT CONFERENCE COSTS
			2022	202I
	Annual conference costs		I94,548	25,248
	Annual support to UKLA		I l,500	I I,500
	Support costs			6,7 I3
			206,048	43,46 I
7.	OTHER ASSOCIATED	CONFERENCE COSTS
			2022	2021
				E
	Travel & hotels		2,242	584
	Artwork/design & print		3,536	I I5
	CPD application		284	56I
	Bank charges		4, I96	4,8I4
	Website		6,I85	4,507
	Secretarial support costs		5,75 I	4,004
	EBSCosts		175,204	I40,275
	Credit release - Swansea HE			(37,4 I8)
			I97,398	I I7,442
8.	SUPPORT COSTS
				Governance
				costs
	Other resources expended			l3,476
9.	NET INCOME/(EXPENDITURE)
	Net income/(expenditure)	is stated after charging/(crediting):
			2022	202 I
	Accountancy fees		5,047	4,020

					Unrestricted	Restricted	Total
					funds	funds	funds
					f.	f
	INCOME AND ENDOWMENTS			FROM
	Membership subscriptions				94,339		94,339
	Conference fees &sponsorship		income		128,371		128,371
	Interest receivable				748		748
	Total				223,458		223,458
	EXPENDITURE ON
	Conference costs
	Direct conference costs				43,461		43,461
	Other associated conference costs				117,442		117,442
					160,903		160,903
	NET INCOME				62,555		62,555
	RECONCILIATION	OF FUNDS
	Total funds brought forward				81,476	22,377	103,853
	TOTAL FUNDS CARRIED		FORWARD		144,031	22,377	166,408
12.	FIXEDASSET INVESTMENTS
							Unlisted
							investments
	MARKET VALUE
	At I January 2022 and 31 December 2022
	NET BOOKVALUE
	At 31 December 2022
	At 31 December 2021

					2022	2021
						E
Trade debtors					17,500	10,062
VAT						4,029
Prepayments					393	373
					17,893	14,464
CREDITORS: AMOUNTS			FALLING DUE WITHIN ONE YEAR
Deferred	income
				2022		2021
				E.		E
Deferred	income at	I January	2022	14,000		0
Resources	deferred	during the year		20,300		14,000
Amounts	released from prior		year	(14,000)		0
Deferred	income	at 31 December 2022		20,300		14,000

15.	CREDITORS	:	AMOUN	TS FALLING DU	E AFTER MORE TH	AN ONE YEAR
							2022	2021
	Bursary Fund -		support for members to attend		meetings		20,381	19,643
	Swansea health		economics	work to accompany	HCCUK Projec		(736)	(736)
	BLNA restricted		fund				12,479	12,479
							32,124	31,386
16.	MOVEMENT		IN FUNDS
							Net
							movement	At
						At 1.1.22	in funds	31.12.22
	Unrestricted	funds
	General fund					144,031	(19,030)	125,001
	Restricted funds
	BASL nurses fund					6,627		6,627
	CCA UK Neil	Blenkinsop		donation for
	research only					15,750		15,750
						22,377		22,377
	TOTAL FUNDS					166,408	(19,030)	147,378

Net movement	in funds,	included	in the above are as follows:
				Incoming	Resources	Movement
				resources	expended	in funds
Unrestricted	funds
General fund				397,892	(416,922)	(19,030)
TOTAL FUNDS				397,892	(416,922)	(19,030)
Comparatives	for movement		in funds

					Net
					movement	At
				At 1,1.21	in funds	31.12.21
						f
Unrestricted	funds
General fund				81,476	62,555	144,031
Restricted funds
BASL nurses	fund			6,627		6,627
CCA UK Neil Blenkinsop		donation	for
research only				15,750		15,750
				22,377		22,377
TOTAL FUNDS				103,853	62,555	166,408

			Incoming	Resources	Movement
			resources	expended	in funds
					E
Unrestricted		funds
General	fund		223,458	(160,903)	62,555
TOTAL FUNDS			223,458	(160,903)	62,555

	for the ear ended 31 DEC	EMBER 2022
		2022	2021
			E
INCOME AND ENDOWMENTS
Membership subscriptions
Donations			160
Subscriptions		99,160	94,179
		99,160	94,339
Conference fees &sponsorship	income
Conference income		297,904	128,371
Interest receivable
Interest receivable		828	748
Total incoming resources		397,892	223,458
EXPENDITURE
Direct conference costs
Annual conference costs		194,548	25,248
Annual support to UKLA		11,500	11,500
		206,048	36,748
Other associated conference costs
Travel 8c hotels		2,242	58¹
Artwork/design &print		3,536	115
CPD application		284	561
Bank charges		4,196	4„814
Website		6, 185	4,507
Secretarial support costs		5,751	4,004
EBSCosts		175,204	140,275
Credit release - Swansea HE			(37,418)
		197,398	117,442
Support costs
Governance costs
Accountancy fees		5,047	4,020
Other legal and professional		8,429	2,693
		13,476	6,713
Total resources expended		416,922	160,903
Net (expenditure)/income		(19,030)	62,555